Induction of urokinase receptor expression in nephrotoxic nephritis

Experimental Nephrology

Volumn 9, Issue 6, 2001, Pages 397-404

  Xu, Yichun ^a,b   Berrou, Jeannig ^a,b   Chen, Xin ^a,b   Fouqueray, Bruno ^a   Callard, Patrice ^b   Sraer, Jean Daniel ^a,b   Rondeau, Eric ^a,b  

^a INSERM   (France)

^b HÔPITAL TENON   (France)

Author keywords

Fibrinolysis; Fibrosis; Glomerulonephritis; Urokinase receptor

Indexed keywords

ANTISERUM; FIBRIN; MESSENGER RNA; UROKINASE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CELL ADHESION; CHEMOTAXIS; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FIBRIN DEPOSITION; FIBRINOLYSIS; GLOMERULONEPHRITIS; GLOMERULOSCLEROSIS; IMMUNE COMPLEX NEPHRITIS; IMMUNOHISTOCHEMISTRY; MACROPHAGE; NONHUMAN; PATHOGENESIS; PODOCYTE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEINURIA; RAT;

EID: 0034756860     PISSN: 10187782     EISSN: None     Source Type: Journal    
DOI: 10.1159/000052638     Document Type: Article

References (49)

1. Coagulation in renal diseases: The role of the glomerular hemostasis system and implication for therapy
2. Current treatments of crescentic glomerulonephritis
3. Glomerular tissue factor expression in crescentic glomerulonephritis: Correlation between antigen, activity, and mRNA
4. Tissue factor in crescentic glomerulonephritis
5. The renal plasminogen activating system
6. Sites of synthesis of urokinase and tissue-type plasminogen activators in the murine kidney
7. Different expression of the plasminogen activation system in renal thrombotic microangiopathy and the normal human kidney
8. Plasminogen activator inhibitor in renal fibrin deposits of human nephropathies
9. Glomerular fibrinolytic activity in anti-GBM glomerulonephritis in rabbits
10. Dysfunction of glomerular fibrinolysis in experimental antiglomerular basement membrane antibody glomerulonephritis
11. Cellular receptor for urokinase plasminogen activator
12. Urokinase and urokinase receptor: A paracrine/autocrine system regulating cell migration and invasiveness
13. The urokinase receptor
14. The urokinase receptor: A cell surface, regulated chemokine
15. Requirement for receptor-bound urokinase in plasmin-dependent cellular conversion of latent TGF-beta to TGF-beta
16. Basement membrane type IV collagen degradation: Evidence for the involvement of a proteolytic cascade independent of metalloproteases
17. Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor
18. Upregulation of urokinase receptor expression on migrating endothelial cells
19. IFN-γ, tumor necrosis factor-α, and urokinase regulate the expression of urokinase receptors on human monocytes
20. Regulation of urokinase receptor in monocytelike U937 cells by phorbol ester phorbol myristate acetate
21. Function of the urokinase receptor (CD87) in PMN chemotaxis
22. Expression of the urokinase receptor in vascular endothelial cells is stimulated by basic fibroblast growth factor
23. Effect of thrombin, the thrombin receptor activation peptide, and other mitogens on vascular smooth muscle cell urokinase receptor mRNA levels
24. Urokinase synthesis and binding by glomerular epithelial cells in culture
25. Receptor binding and degradation of urokinase-type plasminogen activator by human mesangial cells
26. Regulation of integrin function by the urokinase receptor
27. Identification of the urokinase receptor as an adhesion receptor for vitronectin
28. A role for caveolin and the urokinase receptor in integrin-mediated adhesion and signaling
29. Urokinase-type plasminogen activator binding to its receptor stimulates tumor cell migration by enhancing integrin-mediated signal transduction
30. Suppression of experimental crescentic glomerulonephritis by deoxyspergualin
31. Cell-induced potentiation of the plasminogen activation system is abolished by monoclonal antibody that recognizes the NH2-terminal domain of urokinase receptor
32. Receptor for urokinase is present in tumor-associated macrophages in ductal breast carcinoma
33. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes)
34. Suppression of endogeneous avidin-binding activity in tissues and its relevance to biotin-avidin detection systems
35. A novel, simple, reliable, and sensitive method for multiple immunoenzyme staining: Use of microwave oven heating to block antibody cross-reactivity and retrieve antigens
36. Isolation and characterization of multiple isoforms of the rat urokinase receptor in osteoblasts
37. Nephrotoxic antiserum identifies a beta-1-integrin on rat glomerular epithelial cells
38. Coordinated expression of the vitronectin receptor and the urokinase-type plasminogen activator receptor in metastatic melanoma cells
39. Integrin-dependent induction of functional urokinase receptors in primary T lymphocytes
40. Deendothelialization in vivo initiates a thrombogenic reaction at the rabbit aorta surface: Correlation of uptake of fibrinogen and anti-thrombin III with thrombin generation by the exposed subendothelium
41. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by anitthrom-bin III-independent inhibitors
42. Glomerular basement membrane-containing immune complexes stimulate tumor necrosis factor and interleukin-containing immune complexes stimulate tumor necrosis factor and interleukin-1 production by human monocytes
43. Internalization of the urokinase-plas-minogen activator inhibitor type-1 complex is mediated by the urokinase receptor
44. Recycling of the urokinase receptor upon internalization of the uPA: Serpin complexes
45. Plasminogen and plasminogen activators protect against renal injury in crescentic glomerulonephritis
46. Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator
47. The urokinase receptor is required for human monocyte chemotaxis in vitro
48. Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix
49. Cytoskeletal changes in podocytes associated with foot process effacement in Masugi nephritis